1,2-dithiol-3-thione has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DA; Kuo, PC; Paraiso, HC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC | 1 |
| Brown, DA; Chang, FL; Kuo, PC; Scofield, BA; Wang, PY; Yen, JH; Yu, IC | 1 |
2 other study(ies) available for 1,2-dithiol-3-thione and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
Topics: Animals; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Macrophage Activation; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Myelin Sheath; Th1 Cells; Th17 Cells; Thiones; Thiophenes | 2018 |
3H-1,2-dithiole-3-thione as a novel therapeutic agent for the treatment of experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Th1 Cells; Th17 Cells; Thiones; Thiophenes | 2016 |